CoronaVirus Fiasco- The Breakdown of Social Cohesion, Economical and Financial Stability

 

[I Vince Cawthron only believe Truth Tellers and I discard Propaganda, Lies and Deceit of Main Stream Media and Governmental Agencies (National and International) and the NWO  Fanatics]

 

Corona Virus Fiasco (the breakdown of  Social Cohesion, Economical and Financial Stability )

 

The official definition of Influenza (Flu) by the (UN) World Health Organisation (WHO)

Influenza is a contagious, acute respiratory illness caused by influenza viruses, usually influenza A or B subtypes. Influenza can cause mild to severe illness, and it may predispose to exacerbations of underlying disease or development of secondary bacterial infections. Some people are at risk for serious influenza complications, such as pregnant women, older people, young children, and people with certain chronic health conditions. Immunization is the best intervention to prevent influenza virus infection. 

The ‘official’ definition of Corona Virus by the WHO – Coronaviruses are a group of related viruses that cause diseases in mammals and birds. In humans, corona viruses cause respiratory tract infections that can be mild, such as some cases of the common cold (among other possible causes, predominantly rhinoviruses), and others that can be lethal, such as SARS, MERS, and COVID-19.

The official definition of Covid-19 by the UN (WHO) –  “Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus.

Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment.  Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness”. 

Note – Influenza (Flu) causes serious illness in older people and people with underlying medical problems. Influenza can progress into conditions like pneumonia, or worsen other chronic issues like chronic obstructive pulmonary disease (COPD) and congestive heart failure, which can quickly become life-threatening. 

 

Toxicity:The degree to which a substance (a toxin or poison) can harm humans or animals. Acute toxicity involves harmful effects in an organism through a single or short-term exposure.

Toxin: a poison of plant or animal origin, especially one produced by or derived from micro organisms and acting as an antigen in the body.

Antigen- a toxin or other foreign substance which induces an immune response in the body, especially the production of antibodies. 

Antibodies – a blood protein produced in response to and counteracting a specific antigen. Antibodies combine chemically with substances which the body recognizes as alien, such as bacteria, viruses, and foreign substances in the blood. 

Immune system – resistant to a particular infection or toxin owing to the presence of specific antibodies or sensitized white blood cells. 

Infection – is the invasion of an organism’s body tissues by disease-causing agents, their multiplication, and the reaction of host tissues to the infectious agents and the toxins they produce.   

Virus: an infective agent that typically consists of a nucleic acid molecule in a protein coat, is too small to be seen by light microscopy, and is able to multiply only within the living cells of a host.

Viral: of the nature of, caused by, or relating to a virus or viruses. 

Agent – a person or thing that takes an active role or produces a specified effect. 

Disease – a disorder of structure or function in a human, animal, or plant, especially one that produces specific symptoms or that affects a specific location and is not simply a direct result of physical injury. 

Viruses Are Not Living Organisms

Firstly, viruses are not living organisms or living microbes.

They do not have a respiratory system, nor do they have a nucleus or digestive system.

Viruses are not alive and viruses are not contagious.

The fear behind Coronavirus, for instance, is wholly unwarranted.

Forget everything you think you know about viruses and bacteria. You have been lied to.

The science of virology is based upon the study of viruses. However, no real footage of viral activity exists (except for a recently released (2018) short footage of an HIV virus which shows merely 20% of the virus theory process). Such footage is merely 3D animation and models.

Viruses are observed in cell cultures/petri-dish environments.

Cell cultures are grown in controlled conditions outside their natural environment, wherein cells are artificially kept alive by fluids that are toxic and do damage to cellular activity.

The Petri dish is one of a small number of laboratory equipment items whose name entered popular culture. It is often used metaphorically, e. g. for a contained community that is being studied as if they were micro organisms in a biology experiment 

 

Flu: Influenza, commonly known as the “flu,” is an extremely contagious respiratory illness caused by influenza A, B and C viruses. 

More than 100 types of cold viruses are known, and new strains of flu evolve every few years. Since both diseases are viral, antibiotics cannot conquer cold or flu. 

Influenza  Types A , B and C viruses: a highly contagious viral infection of the respiratory passages causing fever, severe aching, and catarrh, and often occurring in epidemics.

Type A influenza is capable of infecting animals, although it is more common for people to suffer the ailments associated with this type of flu. Wild birds commonly act as the hosts for this flu virus.

Type A flu influenza is constantly changing and is generally responsible for the large flu epidemics. Type A influenza  is spread by people who are already infected. The most common flu hot spots are those surfaces that an infected person has touched and rooms where he has been recently, especially areas where he has been sneezing.

Type B Influenza

Unlike type A Influenza, type B Influenza is found only in humans. Type B  Influenza may cause a less severe reaction than type A Influenza, but occasionally, type B Influenza can still be extremely harmful. Type B Influenza is not classified by subtype and does not cause pandemics.

Type C Influenza is also found in humans. Milder than either type A or B Influenza. People generally do not become very ill from the Type C influenza. Type C Influenza does not cause epidemics.

Pandemic – (of a disease) prevalent over a whole country or the world. 

Epidemic – a widespread occurrence of an infectious disease in a community at a particular time. 

FluMist vaccine can change each year based on international surveillance and scientists’ estimations about which types and strains of the flu will be most potent that year. Previously, all flu vaccines protected against three influenza viruses: one Influenza A (H3N2) virus, one Influenza A (H1N1) virus, and one Influenza B virus. Today, FluMist and some traditional flu shots generally cover up to four strains: two Influenza A viruses and two Influenza B viruses. 

Vaccine – a substance used to stimulate the production of antibodies and provide immunity against one or several diseases, prepared from the causative agent of a disease, its products, or a synthetic substitute, treated to act as an antigen without inducing the disease. 

Influenza vaccine components – Cell-grown flu vaccine will be quadrivalent. For this vaccine, the influenza A(H3N2) and both influenza B reference viruses are cell-derived, and the influenza A(H1N1) is egg-derived.

Quadrivalent – means four.

 

Ingredients of most Vaccines

Fetal tissue cells (derived from Fetus) which is the tissue from abortion of a Human Fetus used in the growth and research to producing a vaccine

Aluminum Salts (derived from Aluminium which is listed as toxic in the periodic table of elements).

Sugar or gelatin. (Sugar – a sweet crystalline substance obtained from various plants, especially sugar cane and sugar beet. Gelatin – a virtually colourless and tasteless water-soluble protein prepared from collagen (the main structural protein found in skin and other connective tissues, widely used in purified form for cosmetic surgical treatments). 

Formaldehyde (a colourless pungent gas in solution made by oxidizing methanol). The most common health problems in people exposed to formaldehyde include irritation of the eyes, nose, and throat. 

Antibiotics (is a substance produced by one microorganism that selectively inhibits the growth of another. Synthetic antibiotics, usually chemically related to natural antibiotics, have since been produced that accomplish comparable tasks). 

Thimerosal (Mercury-containing preservative used in some vaccines and other products, Mercury is listed as toxic in the periodic table of elements). 

Egg proteins (ovalbumin, ovomucoid, ovoglobulin, conalbumin, vitellin, and vitellenin)

Cell-Based (laboratory grown cultures)

Recombinant (relating to or denoting an organism, cell, or genetic material formed by recombination). 

 

 

_______________________________________________________________

 

The following text is from the World Health Organisation (UN) and I Vince Cawthron do not endorse it all as True.

Seasonal influenza is an acute respiratory infection caused by influenza viruses which circulate in all parts of the world.

The pathogen

There are 4 types of seasonal influenza viruses, types A, B, C and D. Influenza A and B viruses circulate and cause seasonal epidemics of disease.

Influenza A viruses are further classified into subtypes according to the combinations of the hemagglutinin (HA) and the neuraminidase (NA), the proteins on the surface of the virus. Currently circulating in humans are subtype A(H1N1) and A(H3N2) influenza viruses. The A(H1N1) is also written as A(H1N1)pdm09 as it caused the pandemic in 2009 and subsequently replaced the seasonal influenza A(H1N1) virus which had circulated prior to 2009. Only influenza type A viruses are known to have caused pandemics.

Influenza B viruses are not classified into subtypes, but can be broken down into lineages. Currently circulating influenza type B viruses belong to either B/Yamagata or B/Victoria lineage.

Influenza C virus is detected less frequently and usually causes mild infections, thus does not present public health importance.

Influenza D viruses primarily affect cattle and are not known to infect or cause illness in people.

Signs and symptoms

Seasonal influenza is characterized by a sudden onset of fever, cough (usually dry), headache, muscle and joint pain, severe malaise (feeling unwell), sore throat and a runny nose. The cough can be severe and can last 2 or more weeks. Most people recover from fever and other symptoms within a week without requiring medical attention. But influenza can cause severe illness or death especially in people at high risk (see below).

Illnesses range from mild to severe and even death. Hospitalization and death occur mainly among high risk groups. Worldwide, these annual epidemics are estimated to result in about 3 to 5 million cases of severe illness, and about 290 000 to 650 000 respiratory deaths.

In industrialized countries most deaths associated with influenza occur among people age 65 or older (1). Epidemics can result in high levels of worker/school absenteeism and productivity losses. Clinics and hospitals can be overwhelmed during peak illness periods.

The effects of seasonal influenza epidemics in developing countries are not fully known, but research estimates that 99% of deaths in children under 5 years of age with influenza related lower respiratory tract infections are found in developing countries (2).

Epidemiology

All age groups can be affected but there are groups that are more at risk than others.

People at greater risk of severe disease or complications when infected are: pregnant women, children under 59 months, the elderly, individuals with chronic medical conditions (such as chronic cardiac, pulmonary, renal, metabolic, neurodevelopmental, liver or hematologic diseases) and individuals with immunosuppressive conditions (such as HIV/AIDS, receiving chemotherapy or steroids, or malignancy).

Health care workers are at high risk acquiring influenza virus infection due to increased exposure to the patients and risk further spread particularly to vulnerable individuals.

In terms of transmission, seasonal influenza spreads easily, with rapid transmission in crowded areas including schools and nursing homes. When an infected person coughs or sneezes, droplets containing viruses (infectious droplets) are dispersed into the air and can spread up to one meter, and infect persons in close proximity who breathe these droplets in. The virus can also be spread by hands contaminated with influenza viruses. To prevent transmission, people should cover their mouth and nose with a tissue when coughing, and wash their hands regularly.

In temperate climates, seasonal epidemics occur mainly during winter, while in tropical regions, influenza may occur throughout the year, causing outbreaks more irregularly.

The time from infection to illness, known as the incubation period, is about 2 days, but ranges from one to four days.

Diagnosis

The majority of cases of human influenza are clinically diagnosed. However, during periods of low influenza activity and outside of epidemics situations, the infection of other respiratory viruses e.g. rhinovirus (those that cause the common cold), respiratory syncytial virus, parainfluenza and adenovirus can also present as Influenza-like Illness (ILI) which makes the clinical differentiation of influenza from other pathogens difficult.

Collection of appropriate respiratory samples and the application of a laboratory diagnostic test is required to establish a definitive diagnosis. Proper collection, storage and transport of respiratory specimens is the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR). Various guidance on the laboratory techniques is published and updated by WHO. (3)

Rapid influenza diagnostic tests (RIDTs) are used in clinical settings, but they have lower sensitivity compared to RT-PCR methods and their reliability depends largely on the conditions under which they are used.

Treatment

Patients with uncomplicated seasonal influenza:

Patients that are not from a high risk group should be managed with symptomatic treatment and are advised, if symptomatic, to stay home in order to minimize the risk of infecting others in the community. Treatment focuses on relieving symptoms of influenza such as fever. Patients should monitor themselves to detect if their condition deteriorates and seek medical attention Patients that are known to be in a group at high risk for developing severe or complicated illness, (see above) should be treated with antivirals in addition to symptomatic treatment as soon as possible.

Patients with severe or progressive clinical illness associated with suspected or confirmed influenza virus infection (i.e. clinical syndromes of pneumonia, sepsis or exacerbation of chronic underling diseases) should be treated with antiviral drug as soon as possible.

Neuraminidase inhibitors (i.e. oseltamivir) should be prescribed as soon as possible (ideally, within 48 hours following symptom onset) to maximize therapeutic benefits. Administration of the drug should also be considered in patients presenting later in the course of illness.

Treatment is recommended for a minimum of 5 days, but can be extended until there is satisfactory clinical improvement.

Corticosteroids should not be used routinely,, unless indicated for other reasons (eg: asthma and other specific conditions); as it has been associated with prolonged viral clearance, immunosuppression leading to bacterial or fungal superinfection.

All currently circulating influenza viruses are resistant to adamantane antiviral drugs (such as amantadine and rimantadine), and these are therefore not recommended for monotherapy.

WHO GISRS monitors resistance to antivirals among circulating influenza viruses to provide timely guidance for antiviral use in clinical management and potential chemoprophylaxis.

Prevention

The most effective way to prevent the disease is vaccination. Safe and effective vaccines are available and have been used for more than 60 years. Immunity from vaccination wanes over time so annual vaccination is recommended to protect against influenza. Injected inactivated influenza vaccines are most commonly used throughout the world.

Among healthy adults, influenza vaccine provides protection, even when circulating viruses do not exactly match the vaccine viruses. However, among the elderly, influenza vaccination may be less effective in preventing illness but reduces severity of disease and incidence of complications and deaths. Vaccination is especially important for people at high risk of influenza complications, and for people who live with or care for the people at high risk.

WHO recommends annual vaccination for:

pregnant women at any stage of pregnancy

children aged between 6 months to 5 years

elderly individuals (aged more than 65 years)

individuals with chronic medical conditions

health-care workers.

Influenza vaccine is most effective when circulating viruses are well-matched with viruses contained in vaccines. Due to the constant evolving nature of influenza viruses, the WHO Global Influenza Surveillance and Response System (GISRS) – a system of National Influenza Centres and WHO Collaborating Centres around the world – continuously monitors the influenza viruses circulating in humans and updates the composition of influenza vaccines twice a year.

For many years, WHO has updated its recommendation on the composition of the vaccine (trivalent) that targets the 3 most representative virus types in circulation (two subtypes of influenza A viruses and one influenza B virus). Starting with the 2013–2014 northern hemisphere influenza season, a 4th component is recommended to support quadrivalent vaccine development. Quadrivalent vaccines include a 2nd influenza B virus in addition to the viruses in trivalent vaccines, and are expected to provide wider protection against influenza B virus infections. A number of inactivated influenza vaccines and recombinant influenza vaccines are available in injectable form. Live attenuated influenza vaccine is available as a nasal spray.

Pre-exposure or post-exposure prophylaxis with antivirals is possible but depends on several factors e.g. individual factors, type of exposure, and risk associated with the exposure.

Apart from vaccination and antiviral treatment, the public health management includes personal protective measures like:

Regular hand washing with proper drying of the hands

Good respiratory hygiene – covering mouth and nose when coughing or sneezing, using tissues and disposing of them correctly

Early self-isolation of those feeling unwell, feverish and having other symptoms of influenza

Avoiding close contact with sick people

Avoiding touching one’s eyes, nose or mouth

WHO response

WHO, through the WHO GISRS system, in collaboration with other partners, monitors influenza activity globally, recommends seasonal influenza vaccine compositions twice a year for the Northern and Southern hemisphere influenza seasons, guides countries in tropical and subtropical areas to choose vaccine formulations (Northern hemisphere vs. Southern hemisphere), to support decisions for timing of vaccination campaigns, and to support Member States to develop prevention and control strategies.

WHO works to strengthen national, regional and global influenza response capacities including diagnostics, antiviral susceptibility monitoring, disease surveillance and outbreak responses, and to increase vaccine coverage among high risk groups and prepare for the next influenza pandemic.
(1)Estimates of US influenza-associated deaths made using four different methods.
Thompson WW, Weintraub E, Dhankhar P, Cheng OY, Brammer L, Meltzer MI, et al. Influenza Other Respi Viruses. 2009;3:37-49

(2)Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis.
Nair H, Abdullah Brooks W, Katz M et al. Lancet 2011; 378: 1917–3

(3)WHO recommended surveillance standards, Second edition.